New standard of disclosure set for clinical trials

Kondro, Wayne
October 2004
CMAJ: Canadian Medical Association Journal;10/12/2004, Vol. 171 Issue 8, p839
Academic Journal
Focuses on the settlement of a lawsuit filed against GlaxoSmithKline (GSK) for consumer fraud in the U.S. in 2004. Clinical trial registry that should be maintained by GSK under an agreement in the settlement; Importance of the settlement, according to New York State Attorney General Eliot Spitzer; Statement issued by GSK regarding the registry.


Related Articles

  • Legal action against GSK over SSRI data. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;7/6/2004, Vol. 171 Issue 1, p23 

    Focuses on a lawsuit filed by New York State Attorney General Eliot Spitzer against GlaxoSmithKline (GSK) over its alleged failure to disclose important safety and efficacy information concerning the use of its antidepressant paroxetine by minors. Result of a clinical trial on the effect of...

  • GSK: see you in court, again.  // PharmaWatch: CNS;August 2004, Vol. 3 Issue 8, p16 

    A lawsuit alleging that GlaxoSmithKline PLC's (GSK) Seroxat (paroxetine) is a defective product under the Consumer Protection Act will be the latest in a string of legal cases concerning the drug. Lawyers representing the UK Seroxat Users Group are planning to launch a multi-million pound...

  • Calls mounting for drug research transparency. Gebhart, Fred // Drug Topics;9/13/2004, Vol. 148 Issue 17, p47 

    Calls are mounting for greater drug research transparency in the U.S. By filing suit against GlaxoSmithKline, New York attorney general Eliot Spitzer and the American Medical Association set off a wave of publicity that may move the pharmaceutical industry toward greater transparency in drug...

  • THE STATE OF NEW YORK V. GLAXOSMITHKLINE.  // Multinational Monitor;Jul/Aug2004, Vol. 25 Issue 7/8, p38 

    Focuses on the lawsuit filed by New York Attorney General Eliot Spitzer against drug manufacturer GlaxoSmithKline (GSK) for the alleged suppression of clinical study information exhibiting the effectivity of placebo over the anti-depressant paroxetine in children. Response of the company...

  • The sounds of silence.  // Nature Medicine;Jul2004, Vol. 10 Issue 7, p653 

    Presents an editorial that focuses on New York State Attorney General Eliot Spitzer's lawsuit against GlaxoSmithKline (GSK) for repeated and persistent fraud. Contention of Spitzer that the company failed to disclose information on the safety and efficacy of paroxetine for the treatment of...

  • GSK faces US law courts. Beacham, Will // European Chemical News;6/7/2004, Vol. 80 Issue 2103, p7 

    Reports on the lawsuit filed against GlaxoSmithKline by law courts in the U.S. Failure of the company to divulge information on the safety and efficacy of the antidepressant, Paxil; Views of New York State Attorney General Elliot Spitzer on the case; Impact of the lawsuit on the sales of the...

  • Spitzer accuses debt-collection company of illegal practices. Johnson, Mark // Buffalo Law Journal;6/26/2006, Vol. 78 Issue 51, p4 

    The article reports on the lawsuit filed by the office of U.S. Attorney General Eliot Spitzer against national debt-collection company JBC & Associates for illegal and abusive practices that include threats of lawsuits and arrest. The lawsuit charges the accused of trying to collect bad checks...

  • Spitzer to File Suit Vs. Payday Lender. Julavits, Robert // American Banker;9/24/2003, Vol. 168 Issue 184, p3 

    New York Attorney General Eliot Spitzer is expected to file a lawsuit accusing a payday lender of abusive practices. A source in Spitzers office said the institution is County Bank, a community bank headquartered in Rehoboth Beach, Delaware. The $243 million-asset bank, which has eight branches...

  • Eliot Spitzer's winning, but who are the winners? Greenberg, Dean // Inside Tucson Business;10/25/2004, Vol. 14 Issue 15, p8 

    The article discusses issues related to Eliot Spitzer, an Attorney from New York and his role in fighting corruption. People believe that Spitzer is doing some good in challenging the "old boy network." However, the problem is that he might be doing more harm simultaneously. The issue most...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics